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1 |  INTRODUCTION
Physical inactivity and poor dietary habits are major modifi-
able risk factors linked to detrimental changes in cardiomet-
abolic health (WHO, 2017). Large cohort studies revealed 
that a physically inactive lifestyle, either classified as the lack 
of exercise or engagement in sedentary behavior, is strongly 
associated with increased cardiovascular disease (CVD) risk 
(Wilmot et al., 2012). Similarly, habitual high (trans) fat 
and high-calorie dietary intake is associated with increased 
cardiovascular risk and development of CVD (Souza et al., 
(2015)). While the long-term effects of these behaviors are 
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Purpose: The aim of this study was to examine if catechin-rich green tea abrogates 
the negative effects of 7-days of physical inactivity and excessive calorie-intake on 
insulin homeostasis and peripheral vascular function.
Methods: Using a randomized, double-blind, crossover design, twelve healthy men 
(29 ± 6 yrs) underwent 7-days unhealthy lifestyle (UL), including physical inactivity 
(−50% steps/day) and overfeeding (+50% kcal/day). This was combined with green 
tea consumption (UL-tea; 3 doses/day) or placebo (UL-placebo). Before and after 
each intervention, we examined postprandial blood glucose and insulin (3-h after a 
1,202 kcal meal) and upper and lower limb vascular function (flow-mediated dilation 
(FMD%)) and carotid artery reactivity (CAR%).
Results: UL-placebo increased postprandial glucose and insulin, while UL-tea 
 decreased postprandial glucose and insulin (Time*Intervention interaction effects: 
both p < 0.05). UL-placebo decreased CAR% and femoral FMD%, while UL-tea pre-
vented these effects (Time*Intervention interaction effects of p < 0.04 and p < 0.001, 
respectively). There was no main effect of Time or Time*Intervention interaction 
(both p > 0.05) for brachial FMD%.
Conclusion: Seven days of physical inactivity and overfeeding impair insulin ho-
meostasis and vascular function. These effects were mitigated by a daily intake of 
catechin-rich green tea.
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well-established, relatively less work has examined whether 
short periods of an unhealthy (high calories, low physical ac-
tivity) lifestyle affect cardiometabolic risk. Intermittent pe-
riods of unhealthy nutritional and physical activity behavior 
are frequently experienced, such as during holidays, religious 
festivals or forced physical inactivity (e.g., hospitalization, 
injury). Previous work has found that 3–14 days of exposure 
to physical inactivity and/or overfeeding impairs metabolic 
and vascular health (Boyle et al., 2013; Hamburg et al., 2007; 
Knudsen et al., 2012). Exposure to such periods of unhealthy 
behavior may ultimately contribute to the accelerated devel-
opment of cardiometabolic disorders; therefore, effective 
strategies are needed to offset these deleterious effects of a 
short-term unhealthy lifestyle.
Dietary interventions are inexpensive tools to combat the 
ever-increasing burden of CVD. Bioactive compounds known 
as polyphenols are found in plant-derived products, such as 
olive oil, fruits, and vegetables and are suggested to be cardio-
protective and exert a positive influence upon cardiovascular 
health (Mangels & Mohler, 2017). Polyphenols are the most 
abundant antioxidant in the human diet and can be broadly 
categorized into four subclasses: flavonoids, phenolic acids, 
lignans, and stilbenes. Flavonoids account for the greatest 
proportion of polyphenols (60%) and have been linked to a 
reduction in CVD risk (Kim et al., 2016; Ponzo et al., 2015). 
Tea is the major source of dietary flavonoids in many coun-
tries globally (Yahya et al., 2016) and is classified accord-
ing to the fermentation process, where flavonoids present in 
the tea leaf are oxidized following the release of intracellular 
polyphenol oxidase. The four major types of tea are white tea, 
green tea (non-fermented), oolong tea (semi-fermented), and 
black tea (fully fermented). The associated health benefits of 
green tea are attributed to its richness in flavan-3-ols (cate-
chins) (Hodgson & Croft, 2010). The main catechins present 
in green tea are epicatechin (EC), epigallocatechin (EGC), 
epicatechin-3-gallate (ECG), and epigallocatechin-3-gallate 
(EGCG), the most abundant of which is EGCG (~59%) fol-
lowed by EGC (~19%), ECG (~14%) and EC (~6%) (Cabrera 
et al., 2006).
Several biological actions of green tea support the asso-
ciation with a cardioprotective effect, with a direct impact of 
tea on the vasculature, including its effects on the vascular 
endothelium (Grassi, Desideri, et al., 2009), the inner lining 
of all blood vessels which plays a central role in vascular 
homeostasis, and improving the bioactivity of NO (Grassi 
et al., 2013). Furthermore, higher green tea consumption 
is associated with lower blood pressure (Peng et al., 2014) 
and superior endothelial function (Alexopoulos et al., 2008; 
Jochmann et al., 2008), particularly in those with CVD or in 
the postprandial state (Corretti et al., 2002; Park et al., 2010; 
Ras et al., 2011). Clinically, green tea ingestion is also linked 
to lower risk for CVD events and cerebrovascular compli-
cations (e.g., stroke, dementia) (Commenges et al., 2000; 
Vita, 2005). In addition, regular intake of tea, a key dietary 
source of flavonoids, is associated with lower risk for type 
2 diabetes mellitus (Jing et al., 2009; Park et al., 2014). In 
support of this, some laboratory-based studies have found 
tea to acutely improve glucose homeostasis in both healthy 
(Wu et al., 2012), diabetic and obese individuals (Bogdanski 
et al., 2012; Liu et al., 2014; Nagao et al., 2009). The con-
sumption of catechin-rich green tea against a background of 
forced physical inactivity and overfeeding could mitigate the 
negative metabolic and vascular effects of physical inactivity 
and overfeeding, at least in the short-term. Therefore, in this 
study, we tested the hypothesis that the daily consumption of 
green tea abrogates the effects of 7-days unhealthy lifestyle 
(UL: 50% less physical activity and 50% more calories) on 
glucose-insulin homeostasis and vascular function in healthy 
participants.
2 |  PARTICIPANTS AND METHODS
2.1 | Participants
Fourteen healthy, non-smoking, habitually active male 
participants were recruited through local advertisement 
(29  ±  6  yrs, BMI 25  ±  2  kg/m2 and mean arterial pres-
sure 84  ±  8  mmHg). This sample size (effect size of 0.9, 
beta = 0.90, alpha = 0.05) was based on previously reported 
green tea-induced increases in macrovascular function 
(Alexopoulos et al., 2008; Jochmann et al., 2008; Park et al., 
2010) and amelioration of fat loading-induced decrements in 
macrovascular function (Corretti et al., 2002). We excluded 
individuals with vasoactive medications, a history of hyper-
cholesterolemia (cholesterol >6.5 mmol/l), CVD, and/or hy-
pertension (systolic: ≥140 mmHg, diastolic: ≥90 mmHg). We 
also excluded individuals with food allergies, special dietary 
requirements, currently following a diet, and/or those using 
dietary/vitamin supplements. Nine participants were habitual 
users of tea (and coffee). We included physically active indi-
viduals [i.e., >8,000 steps/day; (Tudor-Locke et al., 2011)]. 
Prior to testing, fully informed written consent was obtained. 
The study conformed to the Declaration of Helsinki, was 
approved by Liverpool John Moores University's Research 
Ethics Committee (15/SPS/065) and was registered online 
(clinicaltrials.gov: NCT02777853).
2.2 | Experimental design
First, participants underwent a 4-day monitoring period to re-
cord physical activity level and dietary intake. Subsequently, 
participants underwent a randomized double-blind, placebo-
controlled, crossover trial design of 5 weeks duration; lead-in 
period (1 week); intervention period one (1 week); washout 
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(2 weeks); and finally intervention period two (1 week). A 
2 week washout period was used to allow the systemic elimi-
nation of the tea and unhealthy lifestyle before the initiation 
of the subsequent 1-week intervention which was based on 
previous short-term studies that demonstrated detrimental 
effects of forced physical inactivity and/or overfeeding in-
terventions on insulin sensitivity and macrovascular function 
(Boyle et al., 2013; Hagobian & Braun, 2006; Knudsen et al., 
2012; Parry et al., 2017; Walhin et al., 2013). Participants 
adopted an unhealthy lifestyle in both intervention periods 
but were randomly assigned (computer-generated, simple 
randomization), to tea (UL-Tea) in intervention period one, 
followed by placebo (UL-Placebo) in intervention period 
two, or placebo in intervention period one followed by tea in 
intervention period two. A crossover design was chosen for 
this study instead of the more traditional randomized, paral-
lel-group design because within-participant variation is less 
than between-participant variation allowing for the exami-
nation of possible causal relationships between the interven-
tions (green tea vs. placebo) and the outcomes.
2.3 | Interventions
2.3.1 | Unhealthy Lifestyle (UL)
Based on the 4-day control period, participants reduced daily 
steps by 50%. Real-time feedback on step count was pro-
vided using a pedometer (Digi-walker SW-701, Yamax) and 
verified post hoc via a hip-mounted accelerometer (GT3X 
BT+model, Actigraphy). During the interventions daily ca-
loric intake was increased by 50% (overfeeding) through the 
provision of daily “snack boxes” in addition to participants 
maintaining their normal diet. The snack boxes were made 
up of 60% and 20% of fats and carbohydrates, respectively, 
and typically contained foods such as cheddar cheese, whole 
milk, salami, eggs, white chocolate, and croissants. The par-
ticipants’ baseline dietary ratios of macronutrients were 49% 
carbohydrates, 31% fat, and 20% protein. Participants also 
refrained from foods and beverages high in flavonoids (e.g., 
berries, red wine, dark chocolate) and caffeine during both 
interventions. Dietary patterns were monitored and analyzed 
(MyFitnessPal, Baltimore, Maryland, USA) through self-
reported food diaries. Step count verification was performed 
using accelerometry data (ActiLife 6).
2.3.2 | Tea versus placebo
Participants drank three doses of green tea (UL-Tea, Unilever) 
or placebo (UL-Placebo) per day >15-min before breakfast, 
lunch, and dinner. In a double-blind manner, tea was pro-
vided as a brewed spray-dried tea powder form, supplied in 
identical, coded, laminated aluminium foil sachets. Two sa-
chets were dissolved in 300 ml of boiled water. No additives 
were permitted and tea was consumed while hot. This dose 
of green tea is estimated to contain ~300 mg of flavonoids 
(Astill et al., 2001). Due to a difference in energy intake be-
tween green tea and placebo because of maltodextrin in the 
green tea (19 kcal/day), daily energy intake was adjusted for 
in the daily food intake. Placebo tea had similar color and 
taste like green tea, but did not contain flavonoids or caffeine 
(Table S1; https://figsh are.com/s/8831f 98318 8aba1 3d264). 
Participants were instructed to avoid all other types of tea.
2.4 | Experimental measures
Participants reported to the laboratory before and after each 
7-day intervention. In the week preceding the pre-interven-
tion visits, participants refrained from tea and avoided food 
sources high in flavonoids (Perez-Jimenez et al., 2010). Prior 
to testing, participants fasted for >6-h and refrained from al-
cohol and strenuous physical activity for 24 h. Measurements 
were conducted in a quiet, temperature-controlled laboratory 
(22–24°C) at the same time of day. Upon arrival, anthropo-
metric measurements were recorded, including height (Seca 
stadiometer, model 217, Birmingham, UK) and body mass 
(Seca, model 767, Germany). Before and after each interven-
tion, we examined vascular function and glucose homeosta-
sis/insulin sensitivity responses to a mixed meal tolerance 
test Assessments of vascular function were always conducted 
first followed by the mixed meal tolerance test.
2.5 | Mixed meal tolerance test
A 20G cannula (Venflon Pro) was inserted into the antecubi-
tal vein of one arm and a three-way stopcock (BD Connecta) 
was subsequently attached to enable multiple venous blood 
sampling and flushing of the cannula. Baseline samples 
were collected for glucose (5 ml) and insulin (6 ml), in sil-
ica and EDTA vacutainers, respectively. After baseline as-
sessment, participants consumed a mixed meal (1201 kcal, 
comprising 60% carbohydrates, 33% fat, and 7% protein; 
Table S2; https://figsh are.com/s/8831f 98318 8aba1 3d264; 
https://doi.org/10.6084/m9.figsh are.12246035) in ~15  min 
(Marena et al., 1992). Postprandial blood samples were col-
lected after 30, 60, 90, 120, and 180 min. The rationale for 
using a 180 min postprandial period was in order to ensure 
peak responses and subsequent declines in glucose and in-
sulin were detected as well as previous work that has dem-
onstrated black tea-induced beneficial vascular and insulin 
effects for 180  min after a mixed-meal challenge (Fuchs 
et al., 2016). Following each blood sample, isotonic saline 
(3 ml; B Braun, UK) was used to keep the cannula patent. All 
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blood samples were centrifuged (1,000 g for 10 min at 4°C) 
to obtain plasma samples, which were subsequently stored 
in aliquots at −80°C for later analysis using commercially 
available assays for glucose (Randox, London, UK) and insu-
lin (ELISA-kit, Invitrogen). Plasma glucose was determined 
using an ILab-600 semi-automatic spectrophotometric ana-
lyzer and glucose hexokinase assay (Randox). Plasma insulin 
concentrations were determined using a direct insulin ELISA 
kit (Invitrogen) and insulin levels were determined using 
a monochromator microplate reader (CLARIOstar, BMG 
LABTECH, Ortenberg). Area-under-the-curve (AUCs) for 
postprandial glucose and insulin were calculated above base-
line using the trapezoidal rule.
Insulin sensitivity was estimated using homeostasis model 
assessment (HOMA-IR) (Hanson et al., 2000) and insulin se-
cretion from insulin and glucose levels obtained following the 
standard meal challenge using the Matsuda index (Matsuda 
& DeFronzo, 1999). β-Cell function was assessed with the 
oral disposition index (DIo) (Utzschneider et al., 2009).
2.6 | Vascular function
Peripheral conduit artery, largely NO-mediated, endothe-
lial function was examined at the right brachial and super-
ficial femoral arteries using flow-mediated dilation (FMD) 
(Thijssen et al., 2011). A 10  MHz multi-frequency linear 
array probe, attached to a high-resolution 2D duplex ultra-
sound machine (Terason uSmart 3300, Teratech) was used. 
Pneumatic cuffs (D.E. Hokanson), connected to a rapid in-
flator (D.E. Hokanson), were positioned on the interrogated 
upper forearm and thigh, distal to the imaged site. In addition 
to a stable B-mode image, continuous Doppler velocity and 
diameter data were collected. Baseline images were recorded 
for 1 min, following which the occlusion cuffs were inflated 
(>220 mmHg) for 5 min. Diameter and velocity recordings 
resumed 30  seconds prior to cuff deflation and continued 
for 3 min after cuff deflation, according to methodological 
guidelines (Thijssen et al., 2011).
Central conduit artery endothelial function was measured 
using the carotid artery reactivity test (CAR). The CAR in-
duces carotid artery dilation during sympathetic stimulation 
using the cold pressor test (CPT) and is a surrogate for cor-
onary artery vasomotor function and is inversely associated 
with the presence of cardiovascular risk factors (Mil et al., 
2017; Rubenfire et al., 2000). Duplex ultrasound was used 
to examine the common carotid artery (CCA) before (1 min) 
and during the CPT when participants were instructed to im-
merse their left hand (up to the wrist) in iced slush (1–5°C) 
for 3 min. Participants were instructed to breathe normally 
throughout the CPT and to avoid breath-holding/hyperventi-
lation. Beat-to-beat arterial BP (Finapres Medical Systems) 
and 5-lead ECG were recorded online throughout the CPT 
(LabChart 8.0, AD Instruments). Baseline diameter, velocity, 
shear rate, and blood flow were calculated as the mean of 
data acquired across the 1 min preceding the CPT and during 
the CPT, data were calculated as the mean value for 10-sec-
ond intervals for the 3 min (Mil et al., 2017).
FMD and CAR analysis was performed using custom-de-
signed edge detection software by a single trained researcher 
who was blinded to the treatment allocation (Thijssen et al., 
2011). From the synchronized diameter and velocity data, 
blood flow (the product of cross-sectional area and Doppler 
velocity) and shear rate (four times the velocity divided by 
the diameter) were calculated. Total shear rate area under the 
curve between cuff deflation and peak diameter (SRAUC) 
was calculated and FMD and CAR were automatically calcu-
lated and presented as the peak diameter change from base-
line (in %). The area under the curve for changes in diameter 
during the CPT (CARAUC) was calculated as the percent 
change in the average carotid diameter during the 3-min CPT 
from baseline. As part of the complete study (clinicaltrials.
gov: NCT02777853), we also examined microvascular func-
tion via the assessment of forearm skin blood flow responses 
to local skin heating. However, due to space restrictions and 
this variable being a secondary outcome, these data are only 
presented as supplements (https://figsh are.com/s/ee957 8ba11 
00e86 8861f; https://doi.org/10.6084/m9.figsh are.12659987).
2.7 | Statistical analysis
Data were expressed as mean  ±  SD and statistical signifi-
cance was set at p < 0.05. Linear mixed models were used to 
examine the effect of the 7-day intervention (“Time”: pre vs. 
post), and whether this effect was altered by the type of inter-
vention (“Intervention”: Placebo vs. Tea). The repeated co-
variance type was Unstructured, while we specified”Time,” 
“Intervention,” and “Time*Intervention” as Fixed Effects 
(intercept was included) and as Estimated Marginal Means. 
Significant main or interaction effects were followed up with 
the least significant difference (LSD) approach to multiple 
comparisons (Perneger, 1998). Data were analyzed using 
SPSS 22.0 (SPSS).
3 |  RESULTS
Two participants withdrew prior to completion due to per-
sonal circumstances (n = 1) and being unable to tolerate the 
lifestyle change (n  =  1), while technical issues caused in-
complete data sets for some parameters. One participant was 
unable to complete the cold pressor test due to discomfort 
(n  =  11). Due to problems with venous cannulation, one 
participant did not complete measures of glucose handling 
and insulin homeostasis (n = 11). Self-reported compliance 
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with tea and food boxes was 100%. Compared to baseline 
(11,103 ± 3,385 steps/day), a significant reduction in steps 
was found after UL-Placebo (5,880  ±  1,462 steps/day, 
p < 0.001) and UL-Tea (5,710 ± 1,390 steps/day, p < 0.001) 
with no difference between UL-Placebo and UL-Tea 
(p = 0.75). Energy intake increased during both UL-Placebo 
(3,519 ± 1,279 kcal/day) and UL-Tea (3,516 ± 1,210 kcal/
day) compared to baseline (2,373  ±  864  kcal/day, both 
p < 0.001) with no difference between UL-Placebo and UL-
Tea (p = 0.95). A non-significant increase in body mass was 
found in UL-Placebo (77.4 ± 10.0 to 78.1 ± 11.0 kg) and 
UL-Tea (76.9  ±  9.0 to 77.6  ±  10.6  kg, p  =  0.07), which 
did not differ between interventions (“Time*Intervention”-
interaction: p  =  0.92). A trend for a “Time*Intervention” 
interaction was found for MAP (p  =  0.06), with small, 
non-significant changes in the opposite direction after UL-
Placebo (83 ± 5 vs. 85 ± 5 mmHg) and UL-tea (84 ± 7 vs. 
82 ± 6 mmHg).
3.1 | Mixed-Meal Tolerance Test (MTT)
The 3-h mixed-meal tolerance (MTT) induced a typical ini-
tial increase and subsequent decrease in glucose and insulin 
(Figure 1). A significant “Time*Intervention” interaction ef-
fect was found for glucose and insulin (p = 0.03 and 0.01, 
respectively, Figure 1). Post hoc analysis revealed that post-
prandial AUC for glucose (226 ± 138 vs. 261 ± 162 mmol/L) 
and insulin (12,562 ± 4,498 vs. 16,254 ± 6,803 miu/L) were 
increased in UL-Placebo (both p < 0.05), while postprandial 
AUC for glucose (261 ± 120 vs. 164 ± 113 mmol/L) and in-
sulin (15,225 ± 5,501 vs. 10,533 ± 3,825 miu/L) were signif-
icantly decreased in UL-Tea (both p < 0.05; Figure 2). There 
was a significant “Time*Intervention” interaction (p = 0.01) 
for the Matsuda Index responses with a reduction after UL-
Placebo (3.7 ± 2.0 vs. 3.0 ± 1.3, p < 0.05) but no change after 
UL-Tea (3.3 ± 1.7 vs. 4.2 ± 2.2, p > 0.05). There was no 
significant “Time*Intervention” interaction (p = 0.53) for the 
HOMA-IR responses with no change after either UL-Placebo 
F I G U R E  1  Presentation of glucose (a-b) and insulin (c-D) levels at baseline (0 min) and after a mixed meal tolerance test (MTT; 30, 60, 90, 
120, 150, and 180 min) before (closed symbols) and after (open symbols) a 7-day unhealthy lifestyle (UL) combined with placebo (a, c) or green 
tea (b, d) in healthy male volunteers. Data are presented as means, with error bars representing SD. P-values refer to a 2-way linear mixed model 
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(2.4 ± 1.2 vs. 2.6 ± 0.5) or UL-Tea (2.8 ± 2.1 vs. 2.5 ± 1.8). 
There was no significant “Time*Intervention” interaction 
(p = 0.11) for the β-Cell function responses with no change 
after either UL-Placebo (9.2 ± 10.2 vs. 6.0 ± 4.7) or UL-Tea 
(6.4 ± 5.2 vs. 8.5 ± 6.4).
3.2 | Peripheral vascular function
For the brachial artery, there was no main effect of “Time,” 
“Intervention” or “Time*Intervention” interaction for 
FMD%, baseline diameter or SRAUC (all p > 0.05, Table 
1; Figure 3). For femoral artery FMD, there was a signifi-
cant interaction of “Time*Intervention” (p  <  0.001). Post 
hoc analysis revealed that femoral artery FMD decreased 
after UL-Placebo (e.g., peripheral vascular function was 
worse), but was maintained during UL-Tea (e.g., peripheral 
vascular function did not change; Table 1, Figure 3). No ef-
fects were observed for baseline diameter or SRAUC (all 
p > 0.05, Table 1). No significant main effects of time nor 
time*interaction effects were found for skin microvascular 
function (https://figsh are.com/s/ee957 8ba11 00e86 8861f; 
https://doi.org/10.6084/m9.figsh are.12659987; Table S3 and 
Figures S1 and S2).
3.3 | Central vascular function
For CAR (peak diameter change from baseline), there was 
no main effect of “Time” (p = 0.85), but there was a main 
effect of “Intervention” (p = 0.05) and “Time*Intervention” 
(p  =  0.04). Post hoc analysis showed that CAR decreased 
following UL-Placebo (e.g., central vascular function was 
worse), but was maintained during UL-Tea (e.g., central 
vascular function did not change; Table 1, Figure 4). Similar 
results were evident for CARAUC (the percent change in 
the average carotid diameter during the 3-min CPT); there 
was no main effect of “Time” (p = 0.88), but there was a 
main effect of “Intervention” (p  =  0.04) and a borderline 
“Time*Intervention” interaction (p = 0.08). Post hoc analy-
sis showed that CARAUC decreased following UL-Placebo, 
but was maintained during UL-Tea (Figure 4). Elevations 
F I G U R E  2  Presentation of individual and mean glucose (a-b) and insulin (c-d) AUC responses to a mixed meal tolerance test (MTT) before 
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in systolic and diastolic BP during CAR were not different 
across “Time,” “Intervention” or “Time*Intervention” (all 
p > 0.05, Table 1). Baseline common carotid artery diameter 
did not change after either intervention (p = 0.59) or differed 
between conditions (p = 0.97).
4 |  DISCUSSION
Our study has the following novel observations. Impairments 
in postprandial glucose-insulin homeostasis, and also periph-
eral and central vascular function, in young, healthy men as 
a result of a 7-day unhealthy lifestyle, were ameliorated with 
daily consumption of green tea. These results highlight the 
rapid, detrimental impact of short-term exposure to an un-
healthy lifestyle on metabolic and vascular function, and that 
green tea consumption may (in part) alleviate these effects. 
This work highlights the immediate impact of lifestyle-re-
lated factors on metabolic and cardiovascular health.
In the present study, we found higher blood glucose and 
insulin levels after a mixed-meal challenge (as well as a lower 
Matsuda Index) after 7 days following an unhealthy lifestyle. 
This supports previous findings, in that 3–14 days exposure 
to excessive calorie intake, physical inactivity or both can 
alter glucose and insulin homeostasis (Boyle et al., 2013; 
Hagobian & Braun, 2006; Knudsen et al., 2012; Parry et al., 
2017; Walhin et al., 2013). These findings are clinically rel-
evant since higher postprandial levels of blood glucose and 
insulin fit with the presence of insulin resistance. More im-
portantly, when meals were consistently preceded with green 
tea, we found that these metabolic derangements did not 
occur. Previous studies found that green tea acutely, that is, 
within hours, improves glucose homeostasis in healthy and 
pre-diabetic participants (Bogdanski et al., 2012; Liu et al., 
2014; Nagao et al., 2009; Wu et al., 2012). In addition, long-
term ingestion of green tea has been linked to better met-
abolic health through a range of mechanisms, including, a 
slowing of carbohydrate digestion and glucose absorption, 
stimulation of insulin secretion, a decreased β-cell oxidative 
damage, a modulation of liver glucose release and activa-
tion of glucose uptake receptors in insulin-sensitive tissue 
(Guasch-Ferré et al., 2017). Our study extends these findings 
by revealing that green tea is causally linked to the prevention 
of impairments in metabolic function in response to short-
term exposure to an unhealthy lifestyle. We found signifi-
cant impairments in peripheral and central vascular function, 
T A B L E  1  Brachial and femoral artery FMD%, baseline diameter, time-to-peak and shear rate, and carotid artery reactivity variables before and 
after UL-Placebo and UL-Tea interventions. N = 12 for Brachial and Femoral Artery data. N = 11 for Carotid Artery Reactivity data
Brachial artery
Intervention (mean ± SD) LMM p values
UL-Placebo UL-Tea
Time Intervention T*IPre Post Pre Post
FMD (%) 7.0 ± 2.5 7.0 ± 3.4 7.0 ± 1.2 7.7 ± 1.6 0.20 0.97 0.11
Baseline diameter 
(cm)
0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.40 0.45 0.21
Time-to-peak (s) 40 ± 17 48 ± 22 47 ± 19 43 ± 11 0.65 0.87 0.06
Shear rate (SRAUC) 17456 ± 8205 19407 ± 9026 21046 ± 7317 21411 ± 12650 0.64 0.46 0.16
Femoral Artery
FMD (%) 7.0 ± 3.4 5.0 ± 2.8 6.7 ± 3.6 7.3 ± 3.5 0.10 0.21 0.001
Baseline diameter 
(cm)
0.6 ± 0.1 0.6 ± 0.1 0.6 ± 0.1 0.7 ± 0.1 0.52 0.29 0.32
Time-to-peak (s) 74 ± 49 79 ± 43 54 ± 28 41 ± 22 0.77 0.02 0.30
Shear rate 
(SRAUC)
17882 ± 8353 18187 ± 13450 15904 ± 8525 13659 ± 7965 0.68 0.15 0.16
Carotid artery reactivity
CAR (%) 5.1 ± 1.5 3.3 ± 4.3 5.7 ± 5.3 7.5 ± 4.0 0.87 0.05 0.04
CARAUC (%) 2.6 ± 1.5 1.7 ± 2.2 3.4 ± 3.4 4.2 ± 3.0 0.88 0.04 0.08
Change in SBP 
(mmHg)
28 ± 13 34 ± 15 25 ± 12 26 ± 15 0.27 0.10 0.38
Change in DBP 
(mmHg)
18 ± 6 22 ± 8 18 ± 5 14 ± 5 0.61 0.07 0.05
Data are mean ± SD.
Abbreviations: AUC, area-under-the-curve; CAR, carotid artery reactivity; DBP; diastolic blood pressure; FMD, flow-mediated dilation; SBP, systolic blood pressure; 
SRAUC, shear rate area-under-the-curve; T*I, Time*Intervention-interaction.
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specifically, conduit artery vasodilator capacity to increases in 
flow, that is, femoral FMD, largely NO-mediated (Kooijman 
et al., 2008), was reduced by ~2% points and sympathetic 
stimulation, that is, CAR, likely related to NO (Peace et al., 
2018), was reduced by ~1.8% points after 7 days of unhealthy 
lifestyle, which did not occur with concomitant consumption 
of green tea. Meta-analyses indicate an 8–13% lower risk of 
CV events per percent point increase in FMD (Thijssen et al., 
2019) and a 2% lower CAR is associated with the presence 
of two CVD risk factors (Mil et al., 2017). Several previous 
studies found that a prolonged and/or extreme unhealthy life-
style, for example, diets high in fat (particularly trans-fat) 
and/or carbohydrate and/or physical inactivity, is associated 
with increased CVD risk (Michas et al., 2014; Skeaff & 
Miller, 2009; Souza et al., 2015), and impaired macrovascu-
lar function (Dow et al., 2015; Nosova et al., 2014) largely 
attributed to endothelial dysfunction from increased oxida-
tive stress and reduced NO bioavailability (Bae et al., 2001). 
Our study, reflecting a real-world situation, that is, holidays, 
further highlights that only a short timeframe, for example, 
7 days, is sufficient to induce clinically meaningful detrimen-
tal vascular effects, which were abrogated by regular daily 
consumption of green tea, likely via improved activation of 
eNOS (Loke et al., 2010) and NO-mediated endothelial func-
tion (Ras et al., 2011), reduced oxidative stress (Bogdanski 
et al., 2012) and/or an improved antioxidant and anti-inflam-
matory capacity (Suliburska et al., 2012). The exact constit-
uent of green tea that causes these beneficial vascular and 
metabolic effects in vivo is not clear. Equivocal evidence 
exists for the role of EGCG (Lorenz et al., 2017; Widlansky 
et al., 2007) and EC (Dower et al., 2015; Schroeter et al., 
2006) and caffeine (Buscemi et al., 2010; Tinahones et al., 
2008) in green tea-induced elevations in macrovascular func-
tion. Further research is needed to identify the mechanism(s) 
that underlie cardiovascular and metabolic benefits of green 
tea.
We found distinct effects in upper and lower limb FMD 
responses whereby divergent changes were evident in femo-
ral FMD (decreases in Placebo but maintenance in Tea) but 
not in brachial FMD. This between-limb discrepancy may 
relate to differences in activity level across the intervention 
period, in that our intervention reduced activity of the lower 
limbs, but not necessarily upper limbs. This may underlie 
the decline in femoral artery FMD, with preserved brachial 
F I G U R E  3  Presentation of individual and mean brachial (a-b) and femoral (c-d) FMD responses before and after a 7-day unhealthy lifestyle 
combined with placebo (a, c) or green tea (b, d) in healthy male volunteers. Error bars represent SD. N = 11. *p < 0.05 versus Pre
(a) (b)
(c) (d)
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FMD. In agreement, previous studies adopting models of 
physical inactivity affecting lower limbs (e.g., bed rest, lower 
limb suspension, step reduction) also report a decline in 
lower limb FMD, with preserved brachial artery FMD (Boyle 
et al., 2013; Hamburg et al., 2007) as shear stress is reduced 
in the lower limb but likely preserved in the upper limb where 
movement is not restricted. Furthermore, the lower limb ves-
sels appear more vulnerable to dysfunction and disease than 
upper limb vascular beds (Fukudome et al., 1997; Restaino 
et al., 2015). Similarly, the lack of a time*condition inter-
action for forearm microvascular function is consistent with 
the aforementioned regional FMD differences and/or differ-
ences in susceptibility for dysfunction in the micro- versus 
macrovasculature.
4.1 | Limitations
Although relatively modest sample size was included, our 
study was sufficiently powered to demonstrate a significant 
impact of an unhealthy lifestyle and tea via a strong methodo-
logical design (i.e., double-blind, within-subjects cross-over) 
across a variety of outcomes from a comprehensive test pro-
tocol. It was not possible to ascribe the detriments in vascular 
and metabolic function specifically to low physical activity 
or overfeeding per se; this was beyond the scope of the study. 
Another limitation is that we adopted self-reported diaries to 
assess participants’ compliance with the caloric intervention 
which may be subject to reporting bias. Moreover, we did 
not determine if the dose and frequency of green tea were 
sufficient to raise the plasma NO bioavailability and whether 
alternative mechanisms were evident (e.g., interaction with 
the gut microbiome). Only young, healthy men were stud-
ied, which limits the findings to this cohort. Clearly, female 
reproductive hormones in premenopausal women, as well as 
postmenopausal status, can alter vascular function. The inter-
action of an unhealthy diet and physically inactive lifestyle 
and the reproductive cycle is an important area that requires 
further investigation. Similarly, the beneficial effects of fla-
vonoids are more evident in diseased or at-risk populations; 
therefore, it is possible that green tea would have a greater ef-
fect in groups with impaired vascular and/or metabolic func-
tion. Finally, green tea was used as the intervention when 
various other types of tea are available, for example, black 
F I G U R E  4  Presentation of individual and mean CAR (a-b) and CARAUC (c-d) responses before and after a 7-day unhealthy lifestyle 
combined with placebo (a, c) or green tea (b, d) in healthy male volunteers. Error bars represent SD. N = 11. *p < 0.05 versus Pre
(a) (b)
(c) (d)
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tea, which shows similar beneficial effects to green tea on 
vascular and metabolic function (Bryans et al., 2007; Grassi, 
Mulder, et al., 2009).
4.2 | Conclusion
In conclusion, our study reveals that only 7 days of an un-
healthy lifestyle, including 50% fewer steps and 50% more 
calories, leads to impaired postprandial metabolic, as well as 
peripheral and central vascular, function in young, healthy 
men. These short-term detrimental metabolic and vascular 
effects were prevented when green tea was consumed daily. 
This suggests that simple dietary adjustments, such as the 
consumption of green tea, may help to avoid short-term det-
rimental effects when healthy participants are transiently ex-
posed to an unhealthy lifestyle.
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